Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: Definitions and challenges in trial design

Clinical Infectious Diseases

Volumn 51, Issue SUPPL. 1, 2010, Pages

  Niederman, Michael S ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; ARTERIAL OXYGEN TENSION; BACTERIAL PNEUMONIA; BRONCHOSCOPY; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; HEALTH CARE; HEALTH CARE ASSOCIATED PNEUMONIA; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; INTENSIVE CARE UNIT; MICROBIOLOGY; MORTALITY; PATHOGENESIS; PATIENT SELECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRACHEOBRONCHITIS; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA; CLINICAL TRIAL (TOPIC); CROSS INFECTION; HEALTH CARE FACILITY; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; CROSS INFECTION; HEALTH FACILITIES; HUMANS; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; TREATMENT OUTCOME;

ANTIINFECTIVE AGENT;

EID: 77955691107     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/653035     Document Type: Conference Paper

References (27)

1. Niederman MS, Craven DE, Bonten MJ, et al. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
2. Klompas M, Platt R. Ventilator-associated pneumonia: the wrong quality measure for benchmarking. Ann Intern Med 2007; 147:803-805.
3. Souweine B, Verber B, Bedos JP, et al. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments. Crit Care Med 1998; 26: 236-244.
4. Carratalà J, Mykietiuk A, Fernández-Sabé N, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167: 1393-1399.
5. Nseir S, Favory R, Jozefowicz E, et al. Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study. Crit Care 2008; 12:R62.
6. Palmer LB, Smaldone GC, Chen JJ, et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008; 36:2008-2013.
7. Resar R, Pronovost P, Haraden C, Simmonds T, Rainey T, Nolan T. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf 2005; 31:243-248.
8. Pugin J, Auckenthaler R, Mili N, et al. Diagnosis of ventilator associated pneumonia by bacteriologic analysis of bronchoscopic and nonbron-choscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143:1121-1129.
9. Luna CM, Blanzaco D, Niederman MS, et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003; 31:676-682.
10. Fartoukh MB, Maitre B, Honore S, Cerf C, Zahar JR, Brun-Buisson C. Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med 2003; 168:173-179.
11. Ramirez P, Garcia MA, Ferrer M, et al. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J 2008; 31:356-362.
12. Campbell GD, Niederman MS, Broughton WA, et al. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies: a consensus statement. Am J Respir Crit Care Med 1996; 153:1711-1725.
13. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical trials group. Am J Respir Crit Care Med 1999; 159:1249-1256.
14. Gastmeier P, Sohr D, Geffers C, Behnke M, Ruden H. Risk factors for death due to nosocomial infection in intensive care unit patients: Findings from the Krankenhaus Infektions Surveillance System. Infect Control Hosp Epidemiol 2007; 28:466-472.
15. Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in gram-negative bacteraemia? A meta-anal-ysis. Lancet Infect Dis 2004; 4:519-527.
16. Weber DJ, Rutala WA, Sickbert-Bennet EE, Samsa GP, Brown V, Nie-derman MS. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol 2007; 28:825-831.
17. Trouillet JL, Vuagnat A, Combes A, Kassis N, Chastre J, Gibert C. Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis 2002; 34:1047-1054.
18. Beardsley JR, Willamson JC, Johnson JW, Ohl CA, Karchmer TB, Bow-ton DL. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 2006; 130:787-793.
19. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596.
20. Nachtigall I, Tamarkin A, Tafelski S, et al. Crit Care Med 2009; 37: 159-166.
21. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290:2588-2598.
22. Niederman MS. De-escalation therapy in ventilator-associated pneumonia. Curr Opin Crit Care 2006; 12:452-457.
23. Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006; 129:1210-1218.
24. The Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006; 355:2619-2630.
25. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005; 33:2184-2193.
26. Beyersmann J, Gastmeier P, Grundmann H, et al. Use of multistate models to assess prolongation of intensive care unit stay due to nos-ocomial infection. Infect Control Hosp Epidemiol 2006; 27:493-499.
27. Shorr AF, Cook D, Jiang X, Muscedere J, Heyland D, Canadian Critical Care Trials Group. Correlates of clinical failure in ventilator-associated pneumonia: Insights from a large randomized trial. J Crit Care 2008;23: 64-73.